Diagnostics
Saudi Arabia’s Vision 2030 sets forth an ambitious plan to diversify the economy, elevate healthcare standards, and foster a thriving life sciences ecosystem. At Ariba & Mac Limited, we are proud to align our mission with this vision — advancing biotechnology, pharmaceutical R&D, and innovation-driven healthcare across the Kingdom.
As a joint venture between Ariba Health Care (USA) and the Mac & Rains Group (Pakistan, UK, Türkiye), we combine international expertise with local execution to strengthen Saudi Arabia’s scientific infrastructure. Through targeted R&D, regulatory alignment, and technology transfer, we aim to catalyze growth in the biopharma and healthcare sectors.
“Our commitment to Vision 2030 is more than strategic — it’s personal. We’re building a sustainable ecosystem where science, innovation, and healthcare outcomes advance hand in hand.”
— Executive Team, Ariba & Mac Limited
Driving Local Innovation, Backed by Global Expertise
Our focus is on empowering Saudi researchers, clinicians, and entrepreneurs to co-develop novel therapies and diagnostic technologies. By localizing manufacturing and fostering technology exchange, we help ensure that the Kingdom’s healthcare transformation is sustainable, self-reliant, and globally competitive.
- Collaborating with Saudi academic and research institutions on biopharma R&D projects.
- Establishing high-compliance laboratories aligned with cGMP, GLP, and ICH standards.
- Facilitating knowledge transfer from global experts to local scientific teams.
- Promoting regulatory alignment with SFDA, MENA, EMEA, FDA, GHC, DRAP, MHRA, and EMA frameworks.
Supporting Vision 2030’s Life Sciences Ambition
Vision 2030 calls for the establishment of a vibrant private sector to complement public healthcare services. Our projects directly contribute to this goal by enabling research-led commercialization, fostering clinical trial capacity, and encouraging investment in biotechnology. We view this not as a short-term opportunity — but as a long-term partnership in Saudi Arabia’s healthcare future.
Through consistent research excellence and strategic partnerships, Ariba & Mac is shaping the Kingdom’s position as a regional leader in medical innovation. Our mission is to bridge global scientific standards with local insight — unlocking value for patients, investors, and society.
The Road Ahead
In the coming years, we will continue to collaborate closely with the Saudi government, academic institutions, and healthcare innovators to advance national R&D capabilities. Together, we are laying the groundwork for a healthier, more self-reliant, and scientifically advanced Kingdom — fulfilling the promise of Vision 2030.